What the AHA/ACC guideline actually says about TM, who stands behind it, and what it does and does not mean.
The 2025 US guideline on high blood pressure names Transcendental Meditation as the only meditation technique by name. The guideline was written by the American Heart Association and the American College of Cardiology and endorsed by eleven other organisations, including the American Medical Association. Recommendation 8 (class 2b) says that stress reduction through TM may be reasonable to prevent or treat elevated blood pressure, as an adjunct to lifestyle or medication. The guideline puts the average effect at 5 to 7 mmHg systolic in people with hypertension. In October 2026 the American College of Cardiology carried the same table over into its pathway for resistant hypertension, that is, hypertension that is hard to treat.
“In adults with or without hypertension, stress reduction through transcendental meditation may be reasonable to prevent or treat elevated BP and hypertension, as an adjunct to lifestyle or medication interventions.”
Recommendation 8, section 5.1 (Stress Reduction). Class 2b, level of evidence B-R, meaning randomised trials. Other forms of stress management, such as breathing techniques and yoga, are covered in a separate recommendation (9) with the same class. TM is the only technique named.
The American Heart Association and the American College of Cardiology wrote the guideline. It was developed in collaboration with, and endorsed by:
They endorse the guideline as a whole; there was no separate vote on TM.
Table 12 of the guideline lists the non-drug interventions. A selection, average change in systolic pressure:
| Intervention | What it involves | With hypertension | Without hypertension |
|---|---|---|---|
| Transcendental Meditation | Training by a professional, then 2 × 20 minutes a day, seated with eyes closed | −5 to −7 mmHg | −5 mmHg |
| Breathing control | Device-guided, under 10 breaths a minute, 15 minutes a day | −5 mmHg | −5 mmHg |
| DASH diet | Fruit, vegetables, whole grains, low-fat dairy | −5 to −8 mmHg | −3 to −7 mmHg |
| Aerobic exercise | 90 to 150 minutes a week | −4 to −8 mmHg | −2 to −7 mmHg |
| Less alcohol | At least halving intake | −4 to −6 mmHg | −3 mmHg |
The guideline adds that these values should not be compared directly, because the studies behind each intervention differ.
Do you have high blood pressure? Discuss it with your GP or cardiologist. Many employers reimburse the course if you discuss it with them, and you can show them this guideline; see the course fee page.
On 5 October 2026 the American College of Cardiology published a decision pathway for resistant hypertension. That is blood pressure that stays above target despite the highest tolerated doses of three complementary blood pressure drugs, one of them a diuretic, or that is only controlled with four or more drugs. After confirming the diagnosis, the pathway starts treatment by intensifying lifestyle: less sodium, a heart-healthy diet, weight management, physical activity, less alcohol, stress management and more potassium. In its summary for clinicians the ACC calls these “active treatment strategies, not background advice”.
Table 3 of the pathway, adapted from the 2025 guideline, lists TM at 5 to 7 mmHg systolic. It is the only meditation technique in the table; the other stress-reduction entry is device-guided slow breathing.
What it is not: a decision pathway is not a new guideline and assigns no recommendation class. It adds no new evidence either. The pathway itself notes that the average effects come mainly from studies in general hypertensive populations and may not reflect the response of patients with resistant hypertension. It also notes that stress-reduction studies were smaller and shorter than those of other lifestyle interventions.
Jones DW, Ferdinand KC, Taler SJ, et al. 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults. Circulation. 2025;152. doi:10.1161/CIR.0000000000001356 · PubMed
Davis LL, Yang E, Blyler CA, et al. Optimizing Blood Pressure Care in Patients With Resistant Hypertension: 2026 ACC Expert Consensus Decision Pathway. J Am Coll Cardiol. Published online 5 October 2026. doi:10.1016/j.jacc.2026.08.028
Read also: What is TM? · Course fee and reimbursement
A free introductory talk, about an hour, where you can ask everything.
Book a free introductory talk